If the 6-month review is because the target population has increased to include children up to 18 years old, then it's a good sign.
If the 6-month review is because there are too much additional data that the FDA need to review in details, then it's not a very good sign.
Also 7 January 2025 is during x-mas and new year holiday period, where few people are on duty at work.
If a decision is made by the FDA there'd be a high likelihood that it will be made in December before everyone starts going away.
If the 6-month review is because the target population has...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.31 |
Change
0.150(13.0%) |
Mkt cap ! $1.490B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.33 | $1.15 | $25.26M | 19.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 161000 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.31 | 50400 | 2 |
View Market Depth
| Last trade - 16.10pm 23/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |